Yamada R H, Wakabayashi Y, Iwashima A, Hasegawa T
Department of Biochemistry, Kyoto Prefectural University of Medicine, Japan.
Biochem Pharmacol. 1988 Sep 15;37(18):3435-9. doi: 10.1016/0006-2952(88)90693-4.
L-Hydrazinosuccinate has been shown to induce a marked inhibition of liver aspartate aminotransferase isoenzymes in mice. The effects of the drug on the amino acid content of liver were studied. Intraperitoneal administration of L-hydrazinosuccinate enormously increased the citrulline content of liver and plasma in 6 hr and, less markedly, increased the glutamate and ammonia content of liver with a simultaneous decrease in the aspartate content. Drug administration also induced a marked increase in the liver mitochondrial activity of citrulline formation from ornithine, ammonia and carbon dioxide, with a similar increase in N-acetylglutamate content; a prominent increase in liver tryptophan dioxygenase activity; and an elevated level of plasma corticosterone. The increase of citrulline was interpreted to be produced by decreased conversion of citrulline to argininosuccinate due to a lack of aspartate because of inhibition of aspartate aminotransferase by the drug and increased formation of citrulline due to increases of glutamate and ammonia, which further induced the increase of N-acetylglutamate, because of inhibition of aminotransferase as well as stimulation of amino acid degradation by glucocorticoids.
已证明L-肼基琥珀酸酯可显著抑制小鼠肝脏中的天冬氨酸氨基转移酶同工酶。研究了该药物对肝脏氨基酸含量的影响。腹腔注射L-肼基琥珀酸酯6小时后,肝脏和血浆中的瓜氨酸含量大幅增加,肝脏中的谷氨酸和氨含量略有增加,同时天冬氨酸含量下降。给药还导致肝脏线粒体从鸟氨酸、氨和二氧化碳形成瓜氨酸的活性显著增加,N-乙酰谷氨酸含量也有类似增加;肝脏色氨酸双加氧酶活性显著增加;血浆皮质酮水平升高。瓜氨酸的增加被解释为由于药物抑制天冬氨酸氨基转移酶导致天冬氨酸缺乏,瓜氨酸向精氨琥珀酸的转化减少,以及由于谷氨酸和氨的增加导致瓜氨酸形成增加,进而由于氨基转移酶的抑制以及糖皮质激素对氨基酸降解的刺激导致N-乙酰谷氨酸增加。